Welcome to our dedicated page for Cigna Group news (Ticker: CI), a resource for investors and traders seeking the latest updates and insights on Cigna Group stock.
The Cigna Group (NYSE: CI) news hub provides investors and healthcare professionals with timely updates on this global health services leader. Track official announcements, earnings reports, and strategic developments from Cigna's Evernorth Health Services pharmacy platform and Cigna Healthcare insurance division.
This page aggregates essential updates including regulatory filings, partnership announcements, and innovations in pharmacy benefit management. Stay informed about CI's initiatives in biosimilars adoption, digital health expansion, and value-based care models shaping the healthcare landscape.
Key coverage areas include quarterly financial results, Medicare Advantage updates, international market entries, and leadership changes. All content is sourced from verified corporate communications and reputable financial analysis to ensure reliability.
Bookmark this page for streamlined access to CI's latest developments affecting healthcare markets and investor decisions. Combine our news feed with SEC filings and earnings call transcripts for comprehensive research.
Cigna Corporation (NYSE: CI) has announced a $2.0 billion accelerated stock repurchase (ASR) program with Morgan Stanley and JPMorgan Chase, part of its ongoing share buyback strategy. As of August 4, 2021, Cigna had a remaining buyback authority of $3.8 billion. This repurchase reflects the management's confidence in the company's financial strength and growth strategy. By the end of 2021, Cigna aims to return over $7 billion to shareholders through buybacks and increased dividends. The final settlement of the ASR is expected in Q4 2021.
Cigna Corporation announced new vaccination requirements for its U.S. workforce amid rising COVID-19 cases. Starting September 7, remote employees must be fully vaccinated to enter U.S. worksites. Employees requiring onsite presence must also be fully vaccinated or provide two negative tests weekly from October 18. The policy aims to safeguard employees, clients, and communities. Over 90% of employees have been enabled to work from home, and Cigna has provided incentives like a $200 reward for vaccination. The company has been proactive throughout the pandemic, ensuring safety protocols are in place.
Fresenius Medical Care North America (FMCNA) and Cigna (NYSE: CI) announced an expansion of their collaboration aimed at improving health outcomes and reducing the costs associated with end-stage renal disease (ESRD) care. This agreement extends their program through 2023, building on a partnership initiated in 2017 that has successfully lowered medical costs and hospitalizations for Cigna customers. The program operates under Cigna Collaborative Care, employing a value-based care model that incentivizes healthcare providers to enhance patient care and reduce total costs.
Cigna International has launched the Cigna StressWaves Test, an innovative, online tool that evaluates stress levels using advanced AI technology from Ellipsis Health. This is the first model to analyze both acoustic and semantic voice patterns, providing results within 90 seconds. The test is free, HIPAA and GDPR compliant, and designed for accessibility across devices. With rising mental health concerns globally, this tool aims to help individuals assess their stress early and seek appropriate support. Notably, 83% of people report feeling stressed, highlighting the need for such initiatives.
Express Scripts, a part of Evernorth, has been awarded a 7-year contract by the U.S. Department of Defense for the administration of the TRICARE Pharmacy Program. This contract will serve 9.6 million beneficiaries, including active-duty members, their families, and retirees until 2029. Starting January 2023, Express Scripts will enhance its services, offering specialty care and expanded coordination capabilities while continuing home delivery of medications.
Cigna Corporation (NYSE: CI) reported second quarter 2021 results with total revenues of $43.1 billion and net income of $1.5 billion, yielding $4.25 per share. Adjusted income from operations was $1.8 billion ($5.24 per share). Year-to-date, Cigna repurchased 18 million shares for $4.1 billion. Full year 2021 adjusted revenues are projected at at least $170 billion and adjusted income from operations at at least $6.96 billion ($20.20 per share), despite estimated COVID-19 impacts. Customer relationships increased to 191,111 thousand.
Cigna Corporation (NYSE:CI) has announced significant changes to its Board of Directors, effective September 1, 2021. Isaiah Harris, Jr. will retire at the end of the year after serving as Chair since 2009. Neesha Hathi, currently Chief Digital Officer at Charles Schwab, will join the Board as an independent director. Additionally, David M. Cordani, currently CEO, will take on the role of Chair of the Board beginning January 1, 2022, while Eric Wiseman will serve as Lead Independent Director. These leadership changes aim to enhance Cigna's strategic direction and innovation.
The Board of Directors of Cigna Corporation (NYSE: CI) has declared a cash dividend of $1.00 per share of common stock. This dividend is payable on September 23, 2021, to shareholders on record as of the close of business on September 8, 2021.
Cigna continues to demonstrate commitment to shareholder value through consistent dividend payments.
Cigna Corporation (NYSE: CI) will announce its Q2 2021 financial results on August 5, 2021, at 6:30 a.m. ET. A conference call is scheduled for the same day at 8:30 a.m. ET to discuss the results. Participants are encouraged to join by 8:15 a.m. ET. The call can be accessed via phone or live webcast and a replay will be available starting at 12:30 p.m. ET on August 5 until 11:59 p.m. ET on August 19. Cigna provides integrated health services worldwide, impacting around 190 million customers.
Cigna has appointed Bonnie Evelyn as the new market president for its health care and related benefits plans in Georgia and Alabama, succeeding Bryan Holgerson, who has taken on the role of Chief Underwriting Officer. In her new position, Evelyn will focus on serving clients with over 500 plan employees and enhancing access to affordable health care. With over 25 years of experience, including her current role leading Cigna’s Taft-Hartley and Federal Business segment, her leadership is expected to strengthen Cigna's market position in the region.